ilmscore | Prediction Details
"the company has six programs and pipeline trials for seven indications four of which are in phase two and expecting results within the next two quarters"
By Let's Talk Money! with Joseph Hogue, CFA | September 4, 2024 | Pending
From video
ONE of These 10 Penny Stocks Will Make You Rich 00:12:00 - 00:12:07
Interpreted Prediction
Recursion Pharmaceuticals (RXRX) is expected to announce phase two trial results for four indications within two quarters (from the video publication date of 2024-09-04).

Prediction Details

Ticker
RXRX
Initial Price
6.1 USD

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.